EMD-1201081

DB06181InvestigationalNucleic Acid Based Therapies

Investigated for use/treatment in renal cell carcinoma, solid tumors, and lung cancer.

Mechanism
Curator reviewed
Primary indication
Investigated for use/treatment in renal cell carcinoma, solid tumors, and lung cancer.Curator reviewed
Also known as
Amplivax · IMOXINE
Code names
EMD-1201081 · HYB-2055 · IMO-2055

Resolves to

Compound
UNII8566421Q5RCAS847484-35-9
Targets
Q9NR96TLR9

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action
Listed above
39Drug interactionsStructured to mechanism, not free text
Sign in
6Clinical trialsPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with EMD-1201081, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In